# Treatment for Patients With Osteoarthritis (OA)

> **NCT00110942** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 160 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Systemic AMG 108
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00110942
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-06
- **Final completion:** 2005-11
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2008-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110942, "Treatment for Patients With Osteoarthritis (OA)". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00110942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*